Of note, resveratrol, that has been considered the magic bullet for pulmonary hypertension, limits pulmonary vascular remodeling regulating the NOR-1/cyclin D1 axis via miR-638 [81,119]. This evidence concerns the gene NR4A3 and pulmonary arterial hypertension.